Comparative Evaluation of Amoxicillin–Clavulanate and Ertapenem in an Exploratory Rat Model of ESBL E. coli Peritonitis
Open Access
- 25 February 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 500
Abstract
Background: Extended-spectrum β-lactamase (ESBL)–producing Escherichia coli represent an increasing therapeutic challenge. While ertapenem (ERP) is commonly used as first-line therapy, amoxicillin–clavulanic acid (AMC) achieves therapeutic concentrations in serum and ascitic fluid and may offer a narrower-spectrum alternative. This exploratory preclinical study evaluated whether AMC produces effects comparable to ERP in a rat model of ESBL E. coli peritonitis. Methods: Thirty-three male rats were allocated to four groups: untreated E. coli, AMC, ERP, and sham controls. Peritonitis was induced by intraperitoneal injection of an ESBL-producing E. coli strain. The primary outcome was peritoneal bacterial culture positivity. Secondary outcomes included plasma inflammatory cytokines (CRP, PCT, TNF-α, IL-1β, IL-6), proteomic signaling markers, and histopathological inflammation scores in the peritoneum, spleen, and lungs. Results: One death occurred in the untreated group. Both AMC and ERP were associated with lower peritoneal culture positivity compared with untreated animals, with ERP achieving statistical significance and AMC showing a similar downward trend. Inflammatory cytokines and proteomic markers demonstrated comparable reductions in both treated groups. Histopathology showed reduced inflammatory scores, with AMC exhibiting the lowest peritoneal inflammation. Lung involvement was observed in 7/10 untreated rats versus 5/10 AMC- and ERP-treated rats; these differences were not statistically significant, reflecting the limited sample size. Conclusions: AMC and ERP produced broadly comparable effects on microbiological, biochemical, and inflammatory parameters in ESBL E. coli peritonitis. These findings suggest that AMC may merit further investigation as a potential narrower-spectrum option, though definitive comparisons require larger, adequately powered studies.Keywords
Funding Information
- Research Council of the Saint Joseph University—Faculty of Medicine (FM442)
This publication has 31 references indexed in Scilit:
- Talc Pleurodesis: A Medical, Medicolegal, and Socioeconomic ReviewThe Annals of Thoracic Surgery, 2020
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisThe Lancet Infectious Diseases, 2019
- Caspases and their substratesCell Death & Differentiation, 2017
- Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agentsBioorganic & Medicinal Chemistry, 2016
- Modulation of NF-κB signalling by microbial pathogensNature Reviews Microbiology, 2011
- The diverse functions of GAPDH: Views from different subcellular compartmentsCellular Signalling, 2011
- The Spleen2005
- Structure and function of the spleenNature Reviews Immunology, 2005
- Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patientsJournal of Hepatology, 2000
- Amoxicillin–Clavulanic Acid Therapy of Spontaneous Bacterial Peritonitis: A Prospective Study of Twenty–Seven Cases in Cirrhotic PatientsHepatology, 1990